Next Quarterly Earnings
Wednesday, November 11, 2026
CW 46
Pre-Market
In 76 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Geron
Geron is a US-based biopharmaceutical company specializing in the development of innovative therapies for hematologic malignancies. By focusing on telomerase inhibition, Geron is significantly advancing medical progress in the treatment of blood cancers such as myelodysplastic syndromes (MDS).
Frequently asked questions
When will Geron report its next quarterly earnings?
Geron is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Geron last report quarterly earnings?
Geron last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.02 USD.
How often has Geron beaten expectations?
Geron has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
How do I add the Geron earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
4/5
Quarters above estimates
80%
Beat rate
-14.8%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Geron
Country
🇺🇸
More Financial Information